Catalonia.health is partnering with EY on the fifth session of the Next Health conference series, focused on the transformation the pharmaceutical industry is undergoing due to geopolitical fragmentation, technological competition and mounting pressure on healthcare systems.

In this session, we will analyse how these changes are reshaping the growth strategies of pharmaceutical companies and which capabilities will be needed to compete successfully over the next decade.

Among other topics, we will discuss:

• The emergence of a new global pharmaceutical order and its implications for investment, manufacturing and supply chains.

• How geopolitical, technological and social dynamics are transforming the expectations of patients, healthcare professionals and organisations.

• The role of artificial intelligence as a new driver of strategic competitiveness.

• Which leadership, talent management and change adaptation capabilities will be needed to thrive in an increasingly complex and uncertain environment.

• What characteristics will be shared by the companies that lead the sector in an increasingly multipolar world.

  ---

Agenda:

9:15 a.m. Arrival and coffee

9:30 a.m. Welcome by EY and Catalonia.Health

9:40 a.m. Session led by:

• Hugo Dosil, Partner and Life Sciences Sector Leader at EY Consulting.

• Sol Magaz, Partner at EY Parthenon and Head of the Life Sciences Centre of Excellence.

• Claudia Sureda, Life Sciences Director at EY Consulting.

10:30 a.m. Open discussion with attendees

11:10 a.m. End of session and networking breakfast

Previous sessions of EY’s NextHealth innovation conference series:

• 26 February – How is the health and life sciences sector generating tangible sustainability impact?

• 28 January – The future regulation of medicines and medical devices: challenges and opportunities

• 26 November – Medicines on the move: tackling the challenge and efficiency of pharmaceutical distribution

• 28 October – Cybersecurity in the pharmaceutical industry